MyFinsight
Home
Blog
About
Cash and cash
equivalents
$4,178K
(203.63%↑ Y/Y)
Inventories
$930K
(-37.54%↓ Y/Y)
Accounts receivable and
other receivables,...
$559K
(-55.78%↓ Y/Y)
Prepaid expenses and
other current assets
$72K
(-81.20%↓ Y/Y)
Total current assets
$5,739K
(-24.28%↓ Y/Y)
Other noncurrent
assets
$115K
(-22.30%↓ Y/Y)
Intangible assets, net
$39K
(0.00%↑ Y/Y)
Total assets
$5,893K
(-24.33%↓ Y/Y)
Total liabilities and
stockholders equity
$5,893K
(-24.33%↓ Y/Y)
Total liabilities
$5,260K
(61.60%↑ Y/Y)
Total stockholders'
equity
$633K
(-86.04%↓ Y/Y)
Accumulated deficit
-$291,868K
Common stock warrant
and option...
$3,614K
(155.23%↑ Y/Y)
Total current
liabilities
$1,646K
(-10.49%↓ Y/Y)
Additional paid-in capital
$292,435K
Common stock, 0.001 par
value - 150,000,000...
$66K
Accounts payable and
accrued expenses
$1,383K
(-11.23%↓ Y/Y)
Other current
liabilities
$263K
(-2.59%↓ Y/Y)
Back
Back
Balance Sheet
Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. (RKDA)
source: myfinsight.com